PBM
DCTH icon

Propel Bio Management’s Delcath Systems DCTH Stock Holding History

Propel Bio Management’s Portfolio DCTH Stock Details DCTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.16M Buy
979,698
+541,189
+123% +$5.24M 5.77% 4
2025
Q4 		$4.43M Hold
438,509
– – 3.78% 9
2025
Q3 		$4.71M Buy
438,509
+212,457
+94% +$2.37M 4.72% 8
2025
Q2 		$3.07M Buy
226,052
+48,452
+27% +$676K 3.73% 8
2025
Q1 		$2.26M Buy
177,600
+160,600
+945% +$2.28M 2.63% 10
2024
Q4 		$205K Buy
+17,000
New +$179K 0.2% 18

Other funds holding DCTH

RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PWAC
Private Wealth Advisors (California) Fresno, California $356M AUM 26.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Propel Bio Management's DCTH Position: Q1 2026 in Review

Propel Bio Management increased its Delcath Systems (DCTH) stake by 123% in Q1 2026, buying an estimated $5.24M and bringing the position to 979,698 shares worth $9.16M. The position accounts for 5.77% of the portfolio, ranked #4.

Propel Bio Management first reported a position in DCTH in Q4 2024 and has held it in 6 quarters since. 121 funds tracked by Wall St. Rank hold DCTH as of Q1 2026.

  • Propel Bio Management held 979,698 shares of Delcath Systems worth $9.16M as of Q1 2026.
  • Propel Bio Management bought 541,189 Delcath Systems shares in Q1 2026, an estimated $5.24M.
  • Delcath Systems made up 5.77% of Propel Bio Management's portfolio in Q1 2026, its #4 holding.
  • Propel Bio Management first reported a position in Delcath Systems in Q4 2024 and has held it in 6 quarters since.
  • 121 funds tracked by Wall St. Rank held Delcath Systems as of Q1 2026.

Based on Propel Bio Management's 13F filing for Q1 2026, filed 14 May 2026.